Tag Archives: Cancer Research

May, 2018

1 May
AbbVie and Rice University Establish K.C. Nicolaou Research Accelerator to Advance Therapies in Oncology

NORTH CHICAGO, Ill. and HOUSTON, April 30, 2018 /PRNewswire/ — AbbVie, a research-based global biopharmaceutical company, and Rice University today announced they have entered into a joint research collaboration to establish the K.C. Nicolaou Research Accelerator. The research at the Accelerator will focus on synthesizing novel cytotoxic agents for use …
Share

19 September
VP Biden Announces New Steps to Improve Clinical Trials Essential to Advancing the Cancer Moonshot

“These steps will improve the safety, accessibility and impact of our clinical research system. They will help patients today and help researchers all over the world in their quests to find new cures. And they come at a true inflection point in our fight against cancer. “Clinical trials are essential …
Share

26 August
Fused Genes Found in Esophageal Cancer Cells Offer New Clues on Disease Mechanism

Despite years of research, cellular mechanisms contributing to cancers like esophageal adenocarcinoma have remained elusive. What has puzzled researchers was how genes in the healthy cells lining the esophagus turned the normal cells into malignant ones. Now, researchers from Case Western Reserve University School of Medicine have characterized structurally abnormal …
Share

11 July
International Collaboration to Create New Cancer Models to Accelerate Research

An international project to develop a large, globally accessible, bank of new cancer cell culture models for the research community launches today. The National Cancer Institute (NCI), Cancer Research UK, the Wellcome Trust Sanger Institute and the foundation Hubrecht Organoid Technology are joining forces to develop the Human Cancer Models Initiative (HCMI) …
Share

2 May
New Cancer Drugs Could Treat Lethal Resistant Prostate Cancers

Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests. Researchers found that the drugs, called Hsp90 inhibitors, specifically target and inactivate a mechanism commonly used by prostate cancer …
Share